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Mesoporous silica particles (MSPs) are considered suitable supports to design gated materials 16 
for the encapsulation of bioactive molecules. Folates are essential micronutrients which are 17 
sensitive to external agents that provoke nutritional deficiencies. Folates encapsulation in MSPs 18 
to prevent degradation and to allow their controlled delivery is a promising strategy. 19 
Nevertheless, no information exists about the protective effect of MSPs encapsulation to prevent 20 
their degradation. In this work, 5-formyltetrahydrofolate (FO) and folic acid (FA) were 21 
entrapped in MSPs functionalized with polyamines, which acted as pH-dependent molecular 22 
gates. The stability of free and entrapped vitamins after acidic pH, high temperature and light 23 
exposure was studied. The results showed the degradation of FO after high temperature and 24 
acidic pH, whereas entrapped FO displayed enhanced stability. Free FA was degraded by light, 25 
but MSPs stabilized the vitamin. The obtained results point towards the potential use of MSPs 26 
as candidates to enhance stability and to improve the bioavailability of functional biomolecules. 27 
 28 
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In the last years hybrid organic−inorganic materials have attracted considerable interest due to 45 
the combination of the beneficial characteristic of organic chemistry and material science in 46 
order to develop smart nanodevices. Among different hybrid solids, mesoporous silica particles 47 
(MSPs) offer several unique features that allow the design of gated materials for controlled 48 
release and sensing/recognition protocols [1]. The first family of MSPs called MCM-X was 49 
described in the early 1990s by the Mobil Corporation Laboratories.  This family of silica 50 
supports include different porous silica exhibiting hexagonal (MCM-41), cubic (MCM-48) and 51 
lamellar (MCM-50) pore shapes. After these developments, new ordered materials (e. i. MSU, 52 
KIT, FDU, AMS, SBA…) with a wide range of textural properties have been described by 53 
different authors [2]. MSPs possess broadly advantageous properties such as biocompatibility, 54 
thermal and chemical stability, huge loading capacity, high surface areas, tunable morphologies 55 
and pore sizes, as well as facile functionalization of surfaces and pores [3-7]. The surface 56 
functionalization of MSPs for the development of gated materials allows that the delivery of the 57 
cargo stored in the inorganic support can be triggered by applying selected external stimulus [1]. 58 
Furthermore, it is considered that the inorganic framework can effectively protect the payload 59 
molecules from enzymatic degradation or denaturation caused by environmental changes [7]. 60 
However, there are few studies in the literature about the protective effect of MSPs on the 61 
stability of biomolecules in biological solutions. 62 
The functionalized MSPs have been used to encapsulate drugs mainly for the biomedical field, 63 
but also to encapsulate bioactive molecules for other sectors such as food technology. Different 64 





[19] have been entrapped in gated mesoporous 66 
materials. Most studies have been focused on the development and optimization of the 67 
encapsulation systems for controlled delivery, but it is expected that the MPSs may be able to 68 
enhance the stability of the entrapped bioactive compound.  69 
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Water-soluble vitamins, like folates, are labile compounds in the presence of environmental 70 
agents, such as extreme pH values or high temperatures [20]. As folates are essential for the 71 
human body and cannot be synthesized de novo by the organism, this indispensable vitamin 72 
needs to be obtained from food or dietary supplements [21]. Thus the stability of this vitamin 73 
after storage and processing in food products or supplements should be taken into account. Loss 74 
of the biochemical activity of natural folates can occur during harvest, storage and food 75 
processing [22,23]. In general, pH, temperature, pressure, light and antioxidants, among others, 76 
can affect the stability of the natural folates and the synthetic folic acid (FA) [24-30]. FA, with a 77 
fully oxidized pteridine ring system, exhibits greater stability than folates. Among folates, large 78 
differences in stability exist in susceptibility to oxidative degradation, and 5-79 
formyltetrahydrofolate (FO) is the most stable [31]. Moreover, the stability of folates is 80 
influenced by pH and oxygen, which provokes their oxidation [30,32]. The inclusion of 81 
antioxidant compounds, such as ascorbic acid (AA) or mercaptoethanol, is required to prevent 82 
the destruction of labile folates from thermal exposure and photodegradation during food 83 
processing [20,23,33].  84 
Bearing in mind these factors, it is of interest to create folates encapsulation systems which can 85 
ensure the required dose and fully guarantee the stability and bioavailability of this vitamin. 86 
Therefore, the objective of this study was the encapsulation of FO and FA in a mesoporous 87 
silica support (MCM-41) functionalized with amines to create a system to be used in orally 88 
delivered applications, and to study the stability of entrapped vitamins to test the efficacy of the 89 
MCM-41 support as a protector against external agents, such as acidic pH, high temperature and 90 
light. 91 
  92 
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Materials and methods 93 
Chemicals 94 
Tetraethylorthosilicate (TEOS), N-cetyltrimethylammonium bromide (CTABr), sodium 95 
hydroxide (NaOH), triethanolamine (TEAH3), N-(3-trimethoxysilylpropyl)diethylenetriamine 96 
(N3), sodium phosphate monobasic (NaH2PO4), sodium phosphate dibasic (Na2HPO4) and 97 
tetrabutylammonium hydrogen sulphate (TBAHS) were provided by Sigma-Aldrich (Madrid, 98 
Spain). 5-formyltetrahydrofolate (FO) and folic acid (FA) were purchased from Schircks 99 
Laboratories (Jona, Switzerland). Acetonitrile HPLC grade was provided by Scharlab 100 
(Barcelona, Spain). 101 
 102 
Mesoporous silica particles synthesis 103 
Synthesis of microparticulated MCM-41 particles was carried out following the so-called 104 
“atrane route”, where CTABr was used as the structure-directing agent. A molar ratio, fixed at 7 105 
TEAH3: 2 TEOS:0.52 CTABr:0.5 NaOH:180 H2O. CTABr, was added to a TEAH3 and NaOH 106 
solution, which contained TEOS at 118 ºC. After dissolving CTABr in the solution, water was 107 
slowly added along with vigorous stirring at 70 ºC to form a white suspension. This mixture was 108 
aged at 100 ºC for 24 h. Following synthesis, the solid was recovered, washed with deionized 109 
water and dried at 70 ºC. The as-synthesized microparticles were calcined at 550 ºC in an 110 
oxidant atmosphere for 5 h to remove the template phase [16]. 111 
 112 
Synthesis of encapsulated folates 113 
The design of the encapsulation system was based on a previous work, in which FA was 114 
entrapped in a MSP functionalized with amines to deliver FA during a simulated digestion 115 
process [12]. Dissolutions of FO and FA (10 mg/mL) were prepared in distilled water and 116 
phosphate-buffered saline (PBS), respectively. Solutions were added to 300 mg of MCM-41 in 117 
3 addition cycles (1.5 mL per cycle). After each addition cycle, solids were dried at 37 ºC to 118 
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remove water content. After loading and drying, solids were collected and functionalized with 119 
1.29 mL of N3 using different media; i.e. acetonitrile (E-FO) or acetate buffer at pH 2 (E-FA). 120 
The final mixtures were stirred for 5.5 h at room temperature, isolated by vacuum filtration, 121 
washed with 300 mL of water adjusted to pH 2, and dried at room temperature for 24 h. 122 
 123 
Characterization of solids 124 
Powder X-ray diffraction (PXRD), transmission electron microscopy (TEM), N2 adsorption-125 
desorption isotherms and zeta potential were used to characterize the synthesized materials. 126 
PXRD was performed in a BrukerD8 Advance diffractometer using CuKα radiation (Bruker, 127 
Coventry, UK). For the TEM analysis, particles were dispersed in dichloromethane and 128 
sonicated for 2 min to preclude aggregates. The suspension was then deposited onto copper 129 
grids coated with a carbon film (Aname SL, Madrid, Spain). The MSPs samples were imaged 130 
by JEOL JEM-1010 (JEOL Europe SAS, Croissy-sur-Seine, France) at an acceleration voltage 131 
of 80 kV. The single-particle size was estimated by averaging the measured size values of 50 132 
particles. The N2 adsorption-desorption isotherms were recorded with a Micrometrics 133 
ASAP2010 automated sorption analyzer (Micromeritics Instrument Corporation, Norcross, 134 
USA). Samples were degassed at 90 ºC in vacuum overnight. Specific surface areas were 135 
calculated from the adsorption data within the low pressure range by the BET model. Pore size 136 
was determined following the BJH method. To determine the zeta potential of the materials, a 137 
Zetasizer Nano ZS (Malvern Instruments, UK) was employed. Samples were dispersed in water 138 
at a concentration of 1 mg/mL. Before taking each measurement, samples were sonicated for 2 139 
min to preclude aggregation. The zeta potential was calculated from the particle mobility values 140 
by applying the Smoluchowski model. The average of five recordings was reported as the zeta 141 
potential. Measurements were taken at 25 ºC in triplicate.  142 
  143 
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Release studies 144 
Delivery studies were conducted to test the release capacity of the encapsulation system and to 145 
confirm the functionality of the gates to modulate the release of vitamins according to the pH of 146 
the medium (closed gates at pH 2, opened gates at pH 7.5). To determine the release of FO and 147 
FA from the amine-gated mesoporous support (E-FO and E-FA), 10 mg of the solids were 148 
placed in 25 mL of PBS at pH 2 and pH 7.5. At certain time points (0, 2, 5, 15, 30, 60, 120, 180 149 
min), aliquots were separated, the suspension was filtered and the solution was analyzed by 150 
HPLC.  151 
 152 
Stability assays 153 
The influence of diverse external agents, such as acidic pH, high temperature and light, on the 154 
stability of the free and entrapped vitamin was studied. Free FO and FA were treated, whenever 155 
possible, as the encapsulated vitamin in order to ensure reproducibility. In order to simulate not 156 
only the 3 day-loading (72 h drying at 37°C) of the particles with the vitamin, but also a further 157 
24-hour drying period after functionalization, compounds in their free form were incubated for 158 
96 h at 37°C. The stability assays with the free vitamin were all conducted with these incubated 159 
samples (F-FO and F-FA).  160 
For the stability assays, 4 mg of the entrapped vitamins (E-FO and E-FA) and the 161 
correspondent amounts of the free forms (ca. 0.02 mg for FO and ca. 0.3 mg for FA) were 162 
dissolved in 10 mL of PBS (pH 2 or pH 7.5). All the stability experiments were performed in 163 
triplicate. The vitamin recoveries were presented by assuming the percentage recovered under 164 
optimal conditions to be 100% (pH 7.5, no treatment). 165 
 166 
pH stability 167 
These experiments were carried out to study the stability and solubility of vitamins at different 168 
pH values; e.g., the acidic pH at which FO and FA exhibited very low solubility [30,32]. These 169 
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assays allow us to confirm the mechanism of polyamines as molecular gates due to the 170 
transformation of amines (open gate at a neutral/basic pH) into polyammonium groups (closed 171 
gate at an acidic pH). 172 
Firstly, the recovery of free compounds under different pH conditions (pH 1, 2, 3, 4, 5, 6, 7, 8, 173 
9, 10) was examined. Depending on the pH value, PBS was adjusted with H2SO4 and NaOH 1 174 
M according to Wu et al. [32]. Then the correspondent volume of a stock solution of vitamins 175 
was added. After stirring samples for 1 h, they were taken for the HPLC analysis. The second 176 
part of the pH assays was conducted to test the stability behavior of vitamins after neutralization 177 
and to prove the functionality of ascorbic acid and the pH-responsive gated support to protect 178 
vitamins. The encapsulated vitamins were mixed with PBS (pH 2), stirred for 1 h and samples 179 
were taken. pH was adjusted to neutral pH with NaOH 5 M and vitamins were released. The 180 
same procedure was carried out with the free forms in the presence or absence of ascorbic acid. 181 
 182 
Temperature stability 183 
Temperature experiments were performed in an autoclave. Free vitamins were dissolved in PBS 184 
(pH 7.5) and equivalent amounts of encapsulated vitamin were suspended in PBS (pH 2) to 185 
keep the gates closed, and to then undergo the sterilization process. Treatment was conducted at 186 
121°C and 1 bar at different times: 5, 10, 15 min. After treatment, vessels were cooled in an ice 187 
bath before taking samples to be analyzed. The encapsulated samples were released by adjusting 188 
the pH of the suspension from pH 2 to a neutral pH. Delivery was done as previously described. 189 
 190 
Light stability 191 
Two different light sources (visible and ultraviolet (UV) lamps) were used in the stability 192 
assays. Samples were prepared in their free forms (dissolved in PBS pH 7.5) and the impact of 193 
ascorbic acid as an antioxidant (0.1% AA dissolved in PBS) was partially examined. 194 
Experiments were conducted on encapsulated vitamins in PBS (pH 2) and were adjusted to pH 195 
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7.5 after the experiments, as reported above. All the samples were kept inside closed transparent 196 
borosilicate glass vessels (Ø 24 mm, h 45 mm) for different times in order to simulate an 197 
indirect light-induced stress, which can actually occur in real food products. Release of vitamins 198 
was conducted as explained above. 199 
 200 
Folate and folic acid quantification 201 
FO and FA were determined by reversed-phase HPLC following the method described by 202 
Pérez-Esteve et al. [12]. The HPLC instrument consisted in a Hitachi LaChrom Elite liquid 203 
chromatograph (Hitachi Ltd., Tokyo, Japan), equipped with an auto-sampler (modul L-2200) 204 
and an UV detector (model L-2400). A Kromaphase 100 C18 (250 mm x 4.6 mm i.d., 5 µm 205 
particle size analytical column) (Scharlab, Barcelona, Spain) was used for separations. The 206 
wavelength of the UV detector was set at 280 nm. The mobile phase consisted in (A) 0.125 mM 207 
of NaH2PO4, 0.875 mM of Na2HPO4 and 0.4 mM of TBAHS in water and (B) an acetonitrile-208 
mobile phase A 65:35 (v/v). The gradient program was: the mobile phase was run isocratically 209 
for the first 5 min with 90% A and 10% B. The percentage of B was linearly increased to reach 210 
36% at 15 min and 60% at 30 min. The percentage of B was lowered linearly to the original 211 
composition in 5 min, and remained under the initial conditions for 5 min. FO and FA were 212 
quantified according to the external standard method, in which a calibration curve of the peak 213 
area was used against the compound concentration. 214 
 215 
Data analysis 216 
Statistical data processing was performed using Statgraphics Centurion XVI (Statpoint 217 
Technologies, Inc., Warrenton, VA, USA). The influence of the different factors on the release 218 
and stability of the vitamin was analyzed by one-way analysis of variance (One-way ANOVA). 219 
The LSD procedure (least significant difference) was used to test for the differences between 220 




Results and discussion 223 
Synthesis and material characterization 224 
FO and FA were encapsulated in the MSPs that contained gate-like ensembles as devices for 225 
controlled delivery applications. In this work, diethylenetriamine moiety was chosen as the 226 
capping ensemble given its proven properties to control the delivery of cargo molecules from 227 
the voids of MSPs in response to changes in pH [8,12,34]. In a first step, the support was 228 
synthesized by using CTABr as a structure director agent and TEOS as a silica source. After 229 
removing the surfactant by calcination the starting MCM-41 support was obtained. The pores of 230 
MCM-41 were loaded with FO and FA. To obtain the final materials (E-FO and E-FA), the 231 
loaded solids were reacted with N-(3-trimethoxysilylpropyl)diethylenetriamine.  232 
The different supports were characterized by standard techniques. The X-ray patterns of solids 233 
MCM-41 as synthesized (a), calcined (b), loaded with FO and functionalized with amines (c) 234 
and loaded with FA and functionalized with amines (d) can be found in Figure 1. Curve a shows 235 
the expected four peaks of a hexagonal ordered array indexed as (100), (110), (200) and (210) 236 
Bragg reflections. A significant shift in the (100) reflection in the PXRD spectrum of the MCM-237 
41 calcined sample is clearly seen on curve b, which corresponds to a cell contraction related to 238 
the condensation of silanols in the calcination step. Curves c and d show that reflections (110), 239 
(200) and (210) were lost, probably due to a reduced contrast, which can be attributed to the 240 
presence of FO or FA in the pores, and to the anchored N3 molecule. Nevertheless, the 241 
existence of the (100) peak in the PXRD patterns in all cases indicated that the process of pore 242 
loading with FO and FA, and functionalization did not basically modify the typical porosity of 243 





Figure 1. Powder X-ray patterns of the solids (a) MCM-41 as-synthesized, (b) MCM-41 247 
calcined, (c) E-FO and (d) E-FA. 248 
 249 
In addition to PXRD patterns, Fig. 2 shows FESEM and TEM images of the different bare and 250 
functionalized materials. By means of FESEM observation, characterization of the shape and 251 
size of the particles was performed. MCM-41 microparticles showed a size in the microscale 252 
and irregular morphology. The comparison of the images before and after loading with FO and 253 
FA and functionalization with N3 allowed concluding that neither loading nor functionalization 254 
















in the support. After loading with FO and FA and functionalization with polyamines, the MCM-256 
41 mesostructure was also confirmed by the TEM images (Figure 2). The particles are irregular 257 
in shape, with a particle size of 708±102, 779±131 and 752±89 nm for bare calcined MCM-41, 258 
E-FO and E-FA, respectively. Moreover, the typical channels of the mesoporous matrix are 259 
seen as alternate black and white stripes, or as a pseudo hexagonal array of pore voids. 260 
 261 
 262 
Figure 2. Characterization of particle size, particle shape and pore system by means of FESEM 263 
(A-C) and TEM (D-F). (A, D) calcined MCM-41; (B, E) E-FO and (C, F) E-FA. 264 
 265 
The N2 adsorption-desorption isotherms of the starting MCM-41 calcined material, and of the 266 
loaded and functionalized solids, can be found in Figure 3. The MCM-41 material curve shows 267 
a well-defined adsorption step at intermediate P/P0 values, which corresponds to a type IV 268 
isotherm that is typical of mesoporous materials. The isotherms of E-FO and E-FA show 269 
mesoporous system curves with partially filled mesopores. The entrapment of FA in mesopores 270 
D 100 nm 100 nmE 100 nmF
A B C2 mm 2 mm 1 mm
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seemed more efficient than FO, and in exactly the same way as the release studies, which 271 
showed greater FA release.  272 
 273 
 274 
Figure 3. Nitrogen adsorption-desorption isotherms for MCM-41 mesoporous material, E-FO 275 
and E-FA materials. 276 
 277 
Table 1 displays the change in the structural properties of the starting material after the loading 278 
and functionalization processes. The values of specific surface, pore volume and pore size in E-279 
FO and E-FA indicate significant pore blocking and the subsequent absence of appreciable 280 
mesoporosity due to the incorporation of vitamins into the mesopores, as well as a reduced 281 
surface area because of the attachment of amine gates. 282 
 283 
Table 1. Analytical and structural parameters from N2 adsorption-desorption isotherms. 284 
 SBET (m
2
/g) Pore volume (cm
3
/g) Pore size (nm) 
MCM-41 932.61 0.46 2.72 
E-FA 88.75 0.06 - 




































Functionalization efficiency was verified by the zeta potential determinations of bare MCM-41, 286 
MCM-41 loaded with FO/FA, and MCM-41 loaded and functionalized with amines. Bare 287 
particles revealed an average negative zeta potential of -31 mV. After loading particles with 288 
FO/FA, the zeta potential changed slightly to values of ca. -30 mV. Yet after functionalization 289 
with N3, the zeta potential changed positively to values of ca. 50 mV for E-FO and E-FA, 290 
which confirmed the attachment of amines to the particle surface.   291 
 292 
Release studies 293 
The release studies confirmed the mechanism of the amine-gated MSPs to modulate vitamin 294 
release according to the pH of the medium. The pH-dependent releases of the encapsulated FO 295 
and FA are shown in Figure 4. Gates were largely closed at pH 2 and the vitamin was barely 296 
detected, which confirmed that vitamin delivery was hindered by the combination of the low 297 
solubility of the vitamins under acidic conditions, the effect of the amines anchored to the 298 
surface of MSPs and the polyammonium groups-anionic species interaction. At an acidic pH, 299 
polyamines were transformed into polyammonium groups, which adopted a rigid-like 300 
conformation due to Coulombic repulsions and coordinate anions (phosphates present in 301 
solution), which blocked pores and avoided vitamin release [8,34]. 302 
In contrast, FO and FA showed a progressive release among time at pH 7.5. After 2 h, 303 
maximum vitamin releases were obtained at pH 7.5, with 41.9±7.2 mg FO/g solid for E-FO and 304 
84.3±7.8 mg FA/g solid for E-FA. The maximum released amounts were used to calculate the 305 
equivalent amount of solids needed in the stability assays to make a comparison between the 306 
free and encapsulated FO and FA. A sustained release was produced because polyamines were 307 
less protonated at a neutral pH, and the Coulombic repulsion between them and the affinity for 308 
anions significantly reduced. These effects, along with increased vitamin solubility, allowed the 309 
delivery of FO and FA from pores. This pH-responsive delivery effect has been suggested to be 310 
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suitable for releasing vitamins in the gastrointestinal tract (closed gates in the stomach, opened 311 
gates in the intestine) [12]. Encapsulation was also expected to protect vitamins from 312 
degradation after exposure to environmental agents (vide infra). 313 
 314 
 315 
Figure 4. Release profiles of vitamin from the pores of E-FO (A) and E-FA (B) in PBS at pH 316 
2.0 (dotted lines) and pH 7.5 (solid lines). Values are Means ± SD, n = 3. 317 
 318 
Stability assays 319 
The influence of diverse external agents related to food processing or storage, such as pH, 320 
temperature and light, on the stability of free 5-formyltetrahydrofolate and folic acid (F-FO and 321 
F-FA) and the corresponding entrapped vitamins (E-FO and E-FA) was studied. 322 
 323 
pH 324 
The study of the effect of pH on the stability of FO and FA at different pH values was 325 
conducted in two steps. In the first step, water solutions of free FA and FO were adjusted to 326 
different pHs and stirred for 1 h before being analyzed by HPLC. Figure 5 shows the detected 327 
concentrations of FA and FO (in terms of recovery) in the aqueous solutions under all the study 328 
conditions (i.e. pH 1-10). As observed, recoveries reached values of ca. 100% from pH 5 to 10, 329 

















































concentrations of both molecules lowered. The FO concentration in water gradually lowered 331 
from ca. pH 4 to pH 1, whereas this effect was observed for FA below ca. pH 3.   332 
 333 
 334 
Figure 5. F-FO and F-FA recoveries at different pH values. Different letters in the bars indicate 335 
statistically significant differences (p<0.05) from levels of pH. Values are Means ± SD, n = 3. 336 
 337 
The drop in the recovery of FO and FA at an acidic pH can be explained by three phenomena: 338 
(a) loss of solubility; (b) interconversion into other derivatives; (c) oxidative degradation. 339 
Folates are slightly soluble at an acidic pH, and are highly soluble under neutral/basic 340 
conditions due to the protonation and deprotonation of molecules in aqueous environments [32]. 341 
In addition to oxidative degradation, FO can nonenzymatically interconvert with 5,10-342 
methenyltetrahydrofolate through changes in pH, temperature and oxygen [35]. 5,10-343 
methenyltetrahydrofolate is formed by the acidification of 5-formyltetrahydrofolate because one 344 
molecule of water is lost (dehydration), which leads to the cyclization of the molecule in a 345 
reversible manner. The equilibrium gradually shifts toward 5,10-methenyltetrahydrofolate, and 346 
its formation becomes faster the lower pH becomes [36].  347 
Bearing all these factors in mind, which could explain loss of recovery at an acidic pH, in a 348 
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them aqueous solutions of free FA and FO were adjusted to pH 2, stirred for 1 h and then pH 350 
was adjusted to 7.5 before the HPLC analysis. The percentage of vitamins determined at pH 2 351 
and after neutralization to pH 7.5 is shown in Fig. 6A, where almost no recovery of vitamins is 352 
detected after stirring them for 1 h at pH 2 (which agrees with Fig. 5). However, the vitamins 353 
reappeared with a percentage of ca. 40% for F-FO and of ca. 72% for F-FA after neutralizing 354 
the pH. F-FA gave higher values after adjusting to the neutral value than free FO, but none of 355 
them achieved complete recovery. Some studies have revealed that FA might not be soluble at a 356 
low pH [12], but other authors have reported its degradation at an acidic pH [29]. The natural 357 
folate showed less stability at an acidic pH than FA, probably due to degradation [36]. 358 
Similar studies to those shown above have been conducted in the presence of ascorbic acid 359 
(AA), and their results are shown in Fig. 6B. This antioxidant was included because previous 360 
studies have demonstrated that its incorporation increases folate stability as oxidation reactions 361 
are prevented [35]. As for the vitamins supplemented with AA, the F-FO concentration only 362 
slightly increased (from 40% in the absence of AA to 50%). However, AA remarkably 363 
influenced the stability of F-FA, and revealed a recovery of almost 90%.  364 
Lastly, the effect of pH changes on the encapsulated vitamins was studied in order to prove the 365 
protective function of the support. As seen in Fig. 6C, minor vitamin recoveries took place at 366 
pH 2. When pH was adjusted to 7.5, E-FO and E-FA were almost fully detectable with a 367 
recovery of 94% and 99%, respectively. Both encapsulated vitamins were highly preserved in 368 
the acidic environment by the pH-responsive gated material. As a result, the highly protective 369 
function of the MSPs functionalized with amines at a low pH was evidenced by both vitamins. 370 
This approach better improved the stability of vitamins than the strategy reported to enhance the 371 
stability of natural folates (addition of antioxidants). Neither the free form nor the vitamins 372 





Figure 6. FO and FA recoveries after pH changes for free vitamins (A), free vitamins in 376 
presence of ascorbic acid (B) and encapsulated vitamins (C). Different letters in the bars 377 
indicate statistically significant differences (p<0.05) from levels of pH. Values are Means ± SD, 378 
n = 3. 379 
 380 
Temperature 381 
Previous experiments conducted with vitamins dissolved in PBS at temperatures below 100 °C 382 
had no impact on their stability (data not shown). In order to investigate the impact of higher 383 
temperatures on the vitamins, a study was carried out by simulating sterilization conditions (121 384 
°C, 1 bar) at different times. The temperature assays performed in the autoclave are presented in 385 
Figure 7. The results showed that encapsulated folate did not significantly reduce vitamin 386 
content at various exposure times. In contrast, F-FO revealed a significant loss of ca. 27% after 387 
15 min, probably due to the formation of interconversion products [30]. With FA, no significant 388 
differences were obtained for both the E-FA and F-FA results. These results are in accordance 389 
with previous studies that have reported good FA stability after thermal exposure in the solid 390 
state and with dissolution [24,26]. Synthetic vitamin has been suggested to be the most stable 391 
type in the folate group because of its oxidized p-teridin ring [37]. The thermostability of FA 392 
and FO has been previously reported as being similar at a neutral pH [23]. The results obtained 393 
with the encapsulated vitamins revealed that entrapped FO could bear up under thermal pressure 394 
exposure and greater stability after proving FO encapsulation. However, encapsulated FA could 395 






















































































Figure 7. Influence of temperature exposure on the stability of encapsulated (E-) and free (F-) 398 
FO (A) and FA (B) vitamins. Different letters in the bars indicate statistically significant 399 
differences (p<0.05) from levels of time exposure (small letters) and differences between the 400 
encapsulated FO/FA or in their free form (capital letters). Values are Means ± SD, n = 3. 401 
 402 
Light  403 
Previous articles, which have reported the influence of various light sources on the degradation 404 
of synthetic FA, have investigated the impact of visible and UV light on both vitamins [25]. 405 
Preliminary experiments revealed no or very little degradation after 6 h (data not shown). 406 
Therefore, assays were carried out from 8 h to 16 h. 407 
Visible light assays were conducted with a lamp, which generated visible light with an intensity 408 
ca. 8 mW/cm². The results obtained from visible light experiments are presented in Figure 8. 409 
The good stability of FO (Fig. 8A) after light exposure was evidenced. Neither F-FO nor E-FO 410 
showed degradation during visible light exposure.  411 
With FA (Fig. 8B), F-FA showed considerable loss after 8 h of visible light exposure, with a 412 
remaining averaged amount of 40%. Gradual reduction of F-FA was detected up to 12 h 413 
irradiation, with a low value of 12%, and total degradation occurred after 16 h with an average 414 
remaining amount of 3%. Conversely, E-FA was well-protected by the functionalized support 415 


























































Given F-FA’s tendency to be degraded by light in solution, the effect of antioxidant AA was 417 
also evaluated as a strategy to improve stability and to confirm the mechanism of degradation 418 
(i.e. oxidation). Free FA dissolution supplemented with AA showed marginal fluctuation after 419 
16 h of visible light exposure, but appeared to stabilize FA substantially in the same way as the 420 
encapsulation system. 421 
 422 
 423 
Figure 8. Influence of visible light exposure on the stability of encapsulated (E-) and free (F-) 424 
FO (A) and FA (B) in presence or not of ascorbic acid. Different letters in the bars indicate 425 
statistically significant differences (p<0.05) from levels of visible light exposure (small letters) 426 
and differences between the encapsulated FO/FA or in their free form (capital letters). Values 427 
are Means ± SD, n = 3. 428 
 429 
Figure 9 shows the free and encapsulated FO and FA recoveries after UV light exposure with an 430 
estimated intensity of 4 mW/cm². The results revealed that E-FO and F-FO exhibited good 431 
stability under UV light (Fig. 9A). Hence natural folate was highly stable in both the free and 432 
encapsulated forms. FA stability was affected by UV light (Fig. 9B) and F-FA showed losses 433 
after 8 h of UV exposure. As in the visible light assays, the impact of AA enhanced the good 434 
stability of the synthetic vitamin and demonstrated more effective protection than the 435 

































































Figure 9. Influence of UV light exposure on the stability of encapsulated (E-) and free (F-) FO 439 
(A) and FA (B) in presence or not of ascorbic acid. Different letters in the bars indicate 440 
statistically significant differences (p<0.05) from levels of visible light exposure (small letters) 441 
and differences between the encapsulated FO/FA or in their free form (capital letters). Values 442 
are Means ± SD, n = 3. 443 
 444 
Summing up the two light experiments, it was noted that FO did not degrade under either visible 445 
light exposure or UV light stress, but FA was susceptible to visible and UV light exposure. 446 
However, the mesoporous system was able to efficiently protect the vitamin and stability was 447 
greatly enhanced.  448 
This study simulated indirect light-induced stress and, therefore, intensities until degradation 449 
occurred. We were unable to compare these results with previous studies as they all used direct 450 
exposures [25,27,28]. Even though it has been suggested to be considerably more stable at pH 451 
7.5 than in acidic media [29], we detected complete oxidative degradation after 16 h of visible 452 
light and UV exposure. Akhtar et al. [25] suggested the mechanism of this oxidative 453 
degradation as they hinted at degradation being produced in the C9-N10 position. Aqueous 454 
solution can form various radiolytic products, which initiate oxidative dehydrogenation and lead 455 
to an enamine compound. This intermediate form is highly susceptible in acidic media and can 456 
undergo fast degradation. In alkaline media, this decomposition process has been proposed to 457 






























































h of light exposure. This caused final decay in the separation of the p-teridin moiety from p-459 
aminobenzoylglutamate [25,27]. 460 
Encapsulated FA, which was solved in PBS (pH 2) in the stability assays, showed good 461 
stability. Not even the degradation-favorable acidic surrounding could hardly affect E-FA 462 
compared to the free form. Apart from successful FA improvement through encapsulation, 463 
antioxidant AA enhanced stability in the same way. Compared to the well-known protective 464 
mechanism of antioxidants [38], the protective function of the mesoporous support has not been 465 
reported to date, and the stabilizing mechanism remains unclear. Although it is fully accepted 466 
that MSPs show very little absorption within the visible and ultraviolet range [39,40], enhanced 467 
encapsulated vitamin recovery was confirmed herein. The possible role of MSPs as a stability 468 
enhancer could hinder access to weak points (C9-N10 bonding) by entrapping the vitamin in 469 
mesopores in such a way that conformational transformations of the molecule are avoided. 470 
 471 
Conclusions 472 
The successful entrapment of natural FO and synthetic FA in pH-responsive MSPs and the 473 
controlled release of the compounds that mimic the gastrointestinal tract were accomplished 474 
herein. The ability of MSPs to protect vitamins after environmental degradation was clearly 475 
evidenced. The stability assays revealed that encapsulated FO and FA were effectively protected 476 
against degradation at an acidic pH compared to their free from. The sterilization studies 477 
showed that encapsulation allowed vitamins to withstand thermal exposure and enhanced their 478 
stability. The results obtained after exposure to visible and UV light displayed good stability for 479 
free FO, which was not influenced by encapsulation, but improved FA stability after entrapment 480 
in MSPs. When considering the protective effect of MSPs against external agents and acidic 481 
stomach conditions, and progressive delivery with time under the intestinal conditions, the FO- 482 
and FA-loaded supports proposed herein can be considered promising potential systems as 483 
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